Literature DB >> 7496663

Clozapine-induced hypersalivation and the alpha 2 adrenoceptor.

F M Corrigan, S MacDonald, G P Reynolds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496663     DOI: 10.1192/bjp.167.3.412a

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

Review 1.  Pharmacogenetics and psychiatry.

Authors:  Amlan Basu; Eva Tsapakis; Kathy Aitchison
Journal:  Curr Psychiatry Rep       Date:  2004-04       Impact factor: 5.285

Review 2.  Clozapine-induced sialorrhea: pathophysiology and management strategies.

Authors:  Samir Kumar Praharaj; Manu Arora; Sachin Gandotra
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

Review 3.  Pharmacological interventions for clozapine-induced hypersalivation.

Authors:  Rebecca Syed; Katie Au; Caroline Cahill; Lorna Duggan; Yanling He; Victor Udu; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

4.  Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life.

Authors:  Senan Maher; Aoife Cunningham; Niamh O'Callaghan; Fintan Byrne; Colm Mc Donald; Shane McInerney; Brian Hallahan
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-30

5.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 6.  [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].

Authors:  K G Kahl; P Trillenberg; A Kordon; R Lencer; C Klein; J Hagenah
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

Review 7.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.